Cargando…

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

BACKGROUND: Currently, there is contradictory evidence regarding the best strategy to follow after discontinuation of a first biological agent in patients with rheumatoid arthritis (RA). We aimed to compare the long-term efficacy of switching to a second tumor necrosis factor inhibitor (TNFi) versus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogas, Patricia, Plasencia-Rodriguez, Chamaida, Navarro-Compán, Victoria, Tornero, Carolina, Novella-Navarro, Marta, Nuño, Laura, Martínez-Feito, Ana, Hernández-Breijo, Borja, Balsa, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641114/ https://www.ncbi.nlm.nih.gov/pubmed/34868357 http://dx.doi.org/10.1177/1759720X211060910

Ejemplares similares

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2020)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
por: Novella-Navarro, Marta, et al.
Publicado: (2021)

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization
por: Benavent, Diego, et al.
Publicado: (2021)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
por: Rodríguez-Martín, Eulalia, et al.
Publicado: (2020)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2019)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
por: Novella -Navarro, Marta, et al.
Publicado: (2023)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
por: Benavent, Diego, et al.
Publicado: (2020)

Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review
por: Navarro-Compán, Victoria, et al.
Publicado: (2017)

Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions
por: Plasencia, Chamaida, et al.
Publicado: (2015)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
por: Plasencia-Rodríguez, Chamaida, et al.
Publicado: (2023)

Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments—Results of the digireuma study
por: Benavent, Diego, et al.
Publicado: (2022)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
por: Benavent, Diego, et al.
Publicado: (2023)

Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis
por: Arroyo-Villa, Irene, et al.
Publicado: (2014)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020)

Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar
por: Martínez-Feito, Ana, et al.
Publicado: (2020)

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
por: Nuño, Laura, et al.
Publicado: (2020)

Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study
por: Benavent, D., et al.
Publicado: (2023)

Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
por: Benavent, Diego, et al.
Publicado: (2022)

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
por: Navarro-Sarabia, Federico, et al.
Publicado: (2009)

Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?
por: Tornero, C., et al.
Publicado: (2020)

Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy
por: Rodríguez-Prieto, Tamara, et al.
Publicado: (2020)

Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis
por: Arias-de la Rosa, Iván, et al.
Publicado: (2022)

A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
por: Cordero, Oscar J., et al.
Publicado: (2022)

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics
por: Regueiro, Cristina, et al.
Publicado: (2019)

Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
por: Regueiro, Cristina, et al.
Publicado: (2020)

Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia
por: Tornero, C., et al.
Publicado: (2022)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
por: Taylor, Peter C., et al.
Publicado: (2021)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Dopaminergic Agents in Rheumatoid Arthritis
por: Capellino, Silvia
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n66rpfi0qg2ng34ql99lp2ttej